Quick Takeaways
- GREENFIELD INVESTMENTS LTD. filed SCHEDULE 13G for Mangoceuticals, Inc. Common Stock, par value $0.001 per share (MGRX).
- Disclosed ownership: 14%.
- Date of event: 13 Dec 2024.
GREENFIELD INVESTMENTS LTD. - 13 Dec 2024 SCHEDULE 13G Report for Mangoceuticals, Inc. Common Stock, par value $0.001 per share (MGRX)
- Filing Manager
- GREENFIELD INVESTMENTS LTD.
- Reporting Manager
- Greenfield Investments, Ltd
- Symbol
- MGRX
- Shares outstanding
- 3,566,482 shares
- Disclosed Ownership
- 515,000 shares
- Ownership
- 14%
- Form type
- SCHEDULE 13G
- Filing time
- 22 Jan 2025, 17:28:37 UTC
- Date of event
- 13 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"GREENFIELD INVESTMENTS LTD. disclosed 14% ownership in Mangoceuticals, Inc. Common Stock, par value $0.001 per share (MGRX) on 13 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 22 Jan 2025, 17:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Greenfield Investments, Ltd | 14% | 515,000 | 0 | 515,000 | /s/ Peter M. Karam | Peter M. Karam | |
| Peter M. Karam | 14% | 515,000 | 0 | 515,000 | /s/ Peter M. Karam | Peter M. Karam |